Related Experiment Video
Updated: Aug 5, 2026

Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
The GPCR Antagonistic Drug CM-20 Stimulates Mitochondrial Activity in Human RPE Cells
Qing Chang1, Siquan Chen2, Tahua Yang1
1University of Illinois Technology Innovation Lab and Argos Vision Inc., Chicago, United States.
Background:
Mitochondrial dysfunction in retinal pigment epithelium (RPE) is a pathogenic factor in age-related macular degeneration (AMD). Improvement of mitochondrial function may ameliorate RPE bioenergetics status, which may in turn nourish the retinal photoreceptors against degenerative loss.
Objective:
The purpose of this study is to examine the G-protein coupled receptor (GPCR) antagonistic drug CM-20 in modulating mitochondrial function in RPE cells.
Methods:
Human-derived ARPE-19 cell line was differentiated to improve RPE morphology. Dose response of CM-20 was performed to examine mitochondrial membrane potential (MMP). Secondary validation with multiplexed live-cell mitochondrial imaging was performed. Protection of CM-20 to mitochondria against oxidative stress was detected under co-treatment with hydrogen peroxide.
Results:
Treatment with CM-20 elicited a dose-dependent increase of MMP. Multiplexed live-cell mitochondrial imaging showed consistent increase of MMP at an optimal concentration of CM-20 (12.5 μM). MMP was significantly reduced under hydrogen peroxide-induced oxidative stress and treatment with CM-20 showed rescue effects to MMP.
Conclusion:
CM-20 increases mitochondrial function and protects mitochondria under oxidative stress. As both GPCRs and mitochondria are potential drug targets, retinal neuroprotective testing of CM-20 is warranted in animal models of retinal degeneration.
Insights
The drug CM-20 enhances mitochondrial function in retinal pigment epithelium cells and protects them from oxidative stress. Further research in animal models is recommended to explore its potential for treating retinal degeneration.
Area of Science:
- Ophthalmology
- Cell Biology
- Pharmacology
Background:
- Mitochondrial dysfunction in retinal pigment epithelium (RPE) cells is a key factor in age-related macular degeneration (AMD).
- Improving RPE mitochondrial function may support retinal photoreceptors and prevent degenerative loss.
Purpose of the Study:
- To investigate the effects of the G-protein coupled receptor (GPCR) antagonist CM-20 on mitochondrial function in RPE cells.
- To determine if CM-20 can modulate mitochondrial membrane potential (MMP) and protect against oxidative stress.
Main Methods:
- Differentiated human ARPE-19 cells were used to assess CM-20's dose-dependent effects on MMP.
- Multiplexed live-cell mitochondrial imaging validated MMP changes.
- CM-20's protective effects against hydrogen peroxide-induced oxidative stress were evaluated.
Main Results:
- CM-20 treatment resulted in a dose-dependent increase in MMP.
- Optimal CM-20 concentration (12.5 μM) significantly increased MMP.
- CM-20 demonstrated a rescue effect on MMP reduced by oxidative stress.
Conclusions:
- CM-20 enhances mitochondrial function and provides protection against oxidative stress in RPE cells.
- Given that GPCRs and mitochondria are potential therapeutic targets, CM-20 warrants further investigation for retinal neuroprotection.
Related Concept Videos
G-Protein Gated Ion Channels
Sensory organs,...
GPCRs Regulate Adenylyl Cylase Activity
Two...

